Fortis Healthcare, one the leading chain of Hospitals in India, on consolidated basis, reported net profit from continuing operations attributable to owners at Rs 2,635.5 million for the quarter ended June 30, 2021 as compared to net loss of Rs 1,789.2 million for the same quarter in the previous year.

Consolidated total income reported two- fold jump at Rs 14,181.5 million for Q1FY22 as compared to Rs 6,104 million for the corresponding quarter previous year.

On standalone basis, the company has reported net loss at Rs 17.3 million for the quarter ended June 30, 2021 as compared to net profit of Rs 199 million for the same quarter in the previous year.

Total income of the company increased by 53.79% at Rs 2,370.1 million for Q1FY22 as compared Rs 1,541.1 million for the corresponding quarter previous year.

Ravi Rajagopal, Chairman, Board of Directors, Fortis Healthcare stated, "The second wave of the pandemic in Q1 FY22 witnessed the Company reserving approx.50% of its operational bed capacity and making all efforts to provide the best possible care for its patients. We continue to actively support the government in its vaccination program with 24 Fortis facilities currently providing vaccinations."

He added, "The recovery in business in the latter half of Q1 enabled us to maintain traction in our investment plans in the hospital business. Our diagnostics business has done well and the completion of the DDRC acquisition has helped SRL fortify its presence in the state of Kerala. The Company today is well placed to capitalise on the opportunities for growth and consolidation given its expanse, infrastructure and capabilities in clinical excellence and patient care."